Looking for a used or new machine tool?
1,000s to choose from
Machinery-Locator
Hurco MPU Bodor MPU Ceratizit MPU XYZ Machine Tools MPU TDT Machine Tools MPU

Machinery-Locator
The online search from the pages of Machinery Market.

BRIDGEPORT VMC 500 XP
Year 2002. 
Heidenhain TNC410 control, 
8,000rpm, 
16-station tool changer. 
TABLE 840 X 360 
X
Year 2002. Heidenhain TNC410 control, 8,000rpm, 16-station tool changer. TABLE 840 X 360 X...
Reid Machinery Sales

Be seen in all the right places!

Intermach 2020 Toolex 2020 Metal Show & TIB Manufacturing Surabaya 2020 MTA Hanoi ITM Industry Europe 2020 Advanced Engineering 2020 Metaltech 2020 Manufacturing & Supply Chain Expo Machine Tool Indonesia 2020 MACH 2021 FITMA 2021

Mologic awarded £1 million for coronavirus test

Posted on 30 Mar 2020 and read 608 times
Mologic awarded £1 million for coronavirus testMologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, has been awarded £1 million as part of the UK Government’s £46 million international coronavirus (COVID-19) prevention and research funding package.

The funding will be used by Mologic and global partners to develop a point-of-need diagnostic test for the virus — and to initiate research for new vaccine candidates.

Mologic (www.mologic.co.uk) will build on its experience of developing a rapid test kit for Ebola to create a new hand-held device to detect COVID-19.

This will allow health officials to test for the virus at home or in the community, providing results in 10min — without the need for electricity or a laboratory.

Mologic co-founder and chief scientific officer Paul Davis said: “As seen with the COVID-19 outbreak, viruses can quickly transmit between populations, but our knowledge to tackle this threat has also grown exponentially.

“For rapid epidemic preparedness and response, we need to develop a platform that is readily modified according to a novel pathogen, as we are demonstrating through our accelerated programmes for Ebola and COVID-19.”

Mologic medical director Joe Fitchett said: “The COVID-19 outbreak is at a critical juncture; to bring it to an end, we need next-generation diagnostics for use at the point-of-need — at home or in the community, in limited and well-resourced settings.

"Rapid detection of the virus is important to stop its spread; we are pleased that the UK Government has acknowledged this, supporting Mologic and the work of our partners to prevent further outbreaks internationally.”